UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Boeing
BA
$171B
| $451M | 0.11% |
2,478,578
+126,521
| +5% | +$22.6M |
|
177
iShares MSCI Emerging Markets ETF
EEM
$28.8B
| $449M | 0.11% |
10,549,392
-585,536
| -5% | -$24.6M |
|
178
PUT
Cisco
CSCO
$457B
| $445M | 0.11% |
9,371,400
-335,899
| -3% | -$15.9M |
|
179
Deutsche Bank
DB
$69B
| $442M | 0.11% |
27,732,969
+1,364,817
| +5% | +$22.3M |
|
180
Quanta Services
PWR
$100B
| $437M | 0.11% |
1,718,664
+261,174
| +18% | +$69.2M |
|
181
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
| $434M | 0.11% |
5,316,342
-38,734
| -0.7% | -$3.15M |
|
182
PUT
Netflix
NFLX
$299B
| $433M | 0.11% |
6,412,000
-725,000
| -10% | -$45.3M |
|
183
JPMorgan Ultra-Short Income ETF
JPST
$40.1B
| $432M | 0.11% |
8,566,121
-51,926
| -0.6% | -$2.61M |
|
184
CRH
CRH
$63.2B
| $430M | 0.11% |
5,740,919
+2,404,515
| +72% | +$192M |
|
185
Air Products & Chemicals
APD
$65.7B
| $428M | 0.11% |
1,657,881
+148,378
| +10% | +$37.6M |
|
186
Republic Services
RSG
$64.8B
| $427M | 0.11% |
2,196,697
-175,076
| -7% | -$33M |
|
187
Progressive
PGR
$123B
| $424M | 0.1% |
2,039,750
+627,478
| +44% | +$131M |
|
188
iShares Russell Mid-Cap ETF
IWR
$56B
| $419M | 0.1% |
5,173,187
-254,380
| -5% | -$20.7M |
|
189
Colgate-Palmolive
CL
$73.1B
| $419M | 0.1% |
4,318,804
+138,035
| +3% | +$12.7M |
|
190
Booking.com
BKNG
$149B
| $417M | 0.1% |
2,632,225
+107,800
| +4% | +$16M |
|
191
CVS Health
CVS
$133B
| $415M | 0.1% |
7,035,002
-1,027,078
| -13% | -$64.2M |
|
192
Match Group
MTCH
$9.19B
| $414M | 0.1% |
13,612,156
+1,547,102
| +13% | +$48.9M |
|
193
KLA
KLAC
$239B
| $404M | 0.1% |
4,895,510
-433,090
| -8% | -$32M |
|
194
Philip Morris
PM
$297B
| $403M | 0.1% |
3,972,917
+619,184
| +18% | +$60.5M |
|
195
Schwab US Large- Cap ETF
SCHX
$71.8B
| $397M | 0.1% |
18,532,893
-1,048,074
| -5% | -$21.7M |
|
196
VanEck Semiconductor ETF
SMH
$65.2B
| $394M | 0.1% |
1,510,614
+148,026
| +11% | +$34.7M |
|
197
PUT
Bank of America
BAC
$435B
| $393M | 0.1% |
9,879,100
-1,796,700
| -15% | -$68.9M |
|
198
Elevance Health
ELV
$81.5B
| $392M | 0.1% |
723,448
-8,871
| -1% | -$4.69M |
|
199
JPMorgan Equity Premium Income ETF
JEPI
$45.9B
| $391M | 0.1% |
6,892,855
+161,529
| +2% | +$9.14M |
|
200
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.3B
| $390M | 0.1% |
3,640,614
-197,380
| -5% | -$21.1M |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,227 new, 3,693 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,227 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.